Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human circulating dopamine-beta-hydroxylase and epilepsy.

J M Warter, G Coquillat, D Kurtz

    Psychopharmacologia
    |January 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Better Respiratory Education and Treatment Help Empower (BREATHE) study: Methodology and baseline characteristics of a randomized controlled trial testing a transitional care program to improve patient-centered care delivery among chronic obstructive pulmonary disease patients.

    Contemporary clinical trials·2017
    Same author

    Facts on Coronary Artery Disease, Based on a Survey of the Clinical and Pathological Records of 762 Cases: Abstract.

    Transactions of the American Clinical and Climatological Association·2011
    Same author

    Kennedy's Disease Initially Manifesting as an Endocrine Disorder.

    Journal of clinical neuromuscular disease·2008
    Same author

    A giant planet orbiting the 'extreme horizontal branch' star V 391 Pegasi.

    Nature·2007
    Same author

    Myopathy with tubular aggregates and gyrate atrophy of the choroid and retina due to hyperornithinaemia.

    Journal of neurology, neurosurgery, and psychiatry·2006
    Same author

    MAPK activation via 5-hydroxytryptamine 1A receptor is involved in the neuroprotective effects of xaliproden.

    International journal of immunopathology and pharmacology·2005

    Circulatory dopamine-beta-hydroxylase (DBH) activity is lower in some epilepsy patients. Enzyme levels were significantly reduced in individuals experiencing seizures shortly before testing, suggesting a link to sympathetic nervous system changes.

    Area of Science:

    • Neuroscience
    • Biochemistry
    • Clinical Neurology

    Background:

    • Dopamine-beta-hydroxylase (DBH) is a key enzyme in catecholamine synthesis.
    • Altered DBH activity has been implicated in various neurological conditions.
    • Understanding DBH's role in epilepsy is crucial for exploring potential biomarkers and therapeutic targets.

    Purpose of the Study:

    • To investigate the activity levels of circulatory dopamine-beta-hydroxylase (DBH) in human subjects with epilepsy.
    • To determine if DBH activity correlates with seizure occurrence and the sympathetic nervous system's state.

    Main Methods:

    • Measurement of circulatory dopamine-beta-hydroxylase (DBH) activity in human subjects.
    • Comparison of DBH activity between epileptic subjects and normal controls.

    Related Experiment Videos

  • Analysis of DBH activity in relation to recent seizure history and induced seizures.

    • Main Results:

    • Epileptic subjects exhibited lower circulatory DBH activity compared to normal subjects.
    • DBH activity was dramatically reduced in subjects who had an epileptic seizure within 24 hours prior to measurement.
    • DBH activity showed variations during seizures induced by convulsant drugs.

    Conclusions:

    • Circulatory DBH activity may serve as a potential indicator in epilepsy.
    • The observed reductions in DBH activity are likely associated with acute changes in the sympathetic nervous system during or following epileptic seizures.
    • Further research is warranted to elucidate the precise mechanisms and clinical implications of DBH alterations in epilepsy.